SB 726 – Removes the expiration date on certain provisions relating to gender transition

• Sponsor: Hoskins
• LR Number: 3681S.01I
• Committee: Emerging Issues
• Last Action: 1/8/2024 - Second Read and Referred S Emerging Issues Committee
• Journal Page: S108
• Effective Date: August 28, 2024

Current Bill Summary

SB 726 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date.

SARAH HASKINS

Amendments

No Amendments Found.